Management and Mitigation of Human Drug-drug Interaction Risks in the Drug Discovery and Development Phases

George K Dresser, David G Bailey, Brenda F Leake, Ute I Schwarz, Paul A Dawson, David J Freeman, Richard B Kim, Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clinical Pharmacology & Therapeutics. ,vol. 71, pp. 11- 20 ,(2002) , 10.1067/MCP.2002.121152

Paul F. Hollenberg, Ute M. Kent, Namandjé N. Bumpus, Mechanism-Based Inactivation of Human Cytochromes P450s: Experimental Characterization, Reactive Intermediates, and Clinical Implications Chemical Research in Toxicology. ,vol. 21, pp. 189- 205 ,(2008) , 10.1021/TX7002504

Mitchell A Hamman, Melissa A Bruce, Barbara D Haehner‐Daniels, Stephen D Hall, The effect of rifampin administration on the disposition of fexofenadine Clinical Pharmacology & Therapeutics. ,vol. 69, pp. 114- 121 ,(2001) , 10.1067/MCP.2001.113697

Philippe Gallay, Lin, Profile of alisporivir and its potential in the treatment of hepatitis C Drug Design Development and Therapy. ,vol. 7, pp. 105- 115 ,(2013) , 10.2147/DDDT.S30946

S. Inoue, E. M. Howgate, K. Rowland-Yeo, T. Shimada, H. Yamazaki, G. T. Tucker, A. Rostami-Hodjegan, Prediction of in vivo drug clearance from in vitro data. II: Potential inter-ethnic differences Xenobiotica. ,vol. 36, pp. 499- 513 ,(2006) , 10.1080/00498250600683262

D Overbosch, C Gulpen, J Hermans, H Mattie, The effect of probenecid on the renal tubular excretion of benzylpenicillin. British Journal of Clinical Pharmacology. ,vol. 25, pp. 51- 58 ,(1988) , 10.1111/J.1365-2125.1988.TB03281.X

Marica Orioli, Giulio Vistoli, Luca Regazzoni, Alessandro Pedretti, Annunziata Lapolla, Giuseppe Rossoni, Renato Canevotti, Luca Gamberoni, Massimo Previtali, Marina Carini, Giancarlo Aldini, Design, Synthesis, ADME Properties, and Pharmacological Activities of β‐Alanyl‐D‐histidine (D‐Carnosine) Prodrugs with Improved Bioavailability ChemMedChem. ,vol. 6, pp. 1269- 1282 ,(2011) , 10.1002/CMDC.201100042

Sumio Ohtsuki, Chiemi Ikeda, Yasuo Uchida, Yumi Sakamoto, Florence Miller, Fabienne Glacial, Xavier Decleves, Jean-Michel Scherrmann, Pierre-Olivier Couraud, Yoshiyuki Kubo, Masanori Tachikawa, Tetsuya Terasaki, None, Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model Molecular Pharmaceutics. ,vol. 10, pp. 289- 296 ,(2013) , 10.1021/MP3004308

N. J. Proctor, G. T. Tucker, A. Rostami-Hodjegan, Predicting drug clearance from recombinantly expressed CYPs: intersystem extrapolation factors Xenobiotica. ,vol. 34, pp. 151- 178 ,(2004) , 10.1080/00498250310001646353

Rana Rais, Steven Fletcher, James E. Polli, Synthesis and In Vitro Evaluation of Gabapentin Prodrugs that Target the Human Apical Sodium-Dependent Bile Acid Transporter (hASBT) Journal of Pharmaceutical Sciences. ,vol. 100, pp. 1184- 1195 ,(2011) , 10.1002/JPS.22332